CGEM FY 2022 Earnings — Cullinan Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

CGEMCullinan Therapeutics, Inc.

$894M

FY 2022 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

$145M

Net Income

$111M

EPS (Diluted)

$2.38

Cash Flow

Operating Cash Flow

-$127M

Free Cash Flow

-$128M

Stock-Based Comp.

$28M

Balance Sheet

Total Assets

$561M

Total Liabilities

$26M

Stockholders' Equity

$535M

Cash & Equivalents

$156M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$19M	-100.0%
Gross Profit	$0	$19M	-100.0%
Operating Income	$145M	-$68M	+312.9%
Net Income	$111M	-$66M	+269.6%